Literature DB >> 16444901

Genetic mouse models of Alzheimer's disease.

Yann S Mineur1, Declan McLoughlin, Wim E Crusio, Frans Sluyter.   

Abstract

In the current minireview, we focus on genetic mouse models of Alzheimer's disease (AD). Because various excellent, up-to-date reviews, special issues, and reliable websites are already dedicated to the genetics of Alzheimer's disease in general and of animal models in particular, this review is not meant to be comprehensive. Rather, we aim to steer the Alzheimer's novice through the recent mouse literature on AD. Special attention will be paid to genetic models that have been tested behaviorally.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16444901      PMCID： PMC2565471          DOI： 10.1155/NP.2005.299

Source DB:  PubMed          Journal:  Neural Plast        ISSN： 1687-5443            Impact factor:   3.599


  11 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 2.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

3.  Adenosine receptor signaling modulates permeability of the blood-brain barrier.

Authors:  Aaron J Carman; Jeffrey H Mills; Antje Krenz; Do-Geun Kim; Margaret S Bynoe
Journal:  J Neurosci       Date:  2011-09-14       Impact factor: 6.167

Review 4.  Inflammation in neurodegenerative diseases.

Authors:  Sandra Amor; Fabiola Puentes; David Baker; Paul van der Valk
Journal:  Immunology       Date:  2010-02       Impact factor: 7.397

Review 5.  Neurologic and motor dysfunctions in APP transgenic mice.

Authors:  Robert Lalonde; Ken-Ichiro Fukuchi; Catherine Strazielle
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

6.  Immunity and inflammation in neurodegenerative diseases.

Authors:  Giuseppe Cappellano; Miryam Carecchio; Thomas Fleetwood; Luca Magistrelli; Roberto Cantello; Umberto Dianzani; Cristoforo Comi
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

7.  An update of animal models of Alzheimer disease with a reevaluation of plaque depositions.

Authors:  Jung-Eun Lee; Pyung-Lim Han
Journal:  Exp Neurobiol       Date:  2013-06-27       Impact factor: 3.261

8.  Targeting S100B in Cerebral Ischemia and in Alzheimer's Disease.

Authors:  Takashi Mori; Takao Asano; Terrence Town
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-09-02

9.  Mutant presenilin-1 deregulated peripheral immunity exacerbates Alzheimer-like pathology.

Authors:  Yuyan Zhu; Demian Obregon; Huayan Hou; Brian Giunta; Jared Ehrhart; Frank Fernandez; Takashi Mori; William Nikolic; Yangbing Zhao; Dave Morgan; Terrence Town; Jun Tan
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

10.  AAD-2004 Attenuates Progressive Neuronal Loss in the Brain of Tg-betaCTF99/B6 Mouse Model of Alzheimer Disease.

Authors:  In-Sun Baek; Tae-Kyung Kim; Ji-Seon Seo; Kang-Woo Lee; Young Ae Lee; Jaeyoung Cho; Byoung Joo Gwag; Pyung-Lim Han
Journal:  Exp Neurobiol       Date:  2013-03-31       Impact factor: 3.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.